Robert A van den Berg (Robert van den Berg)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Top Venues

Scientific reports

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Margherita Coccia, Wivine Burny, Marie-Ange Demoitié, Paul Gillard, Robert A van den Berg, Robbert van der Most
Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses. PloS one 17 (11) (2022)
Laurane de Mot, Viviane Bechtold, Vanesa Bol, Andrea Callegaro, Margherita Coccia, Ahmed Essaghir, Dicle Hasdemir, Fernando Ulloa-Montoya, Emilio Siena, Age Smilde, Robert A van den Berg, Arnaud M Didierlaurent, Wivine Burny, Robbert G van der Most
Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature. Science translational medicine 12 (569) (2021)
January Weiner, David J M Lewis, Jeroen Maertzdorf, Hans-Joachim Mollenkopf, Caroline Bodinham, Kat Pizzoferro, Catherine Linley, Aldona Greenwood, Alberto Mantovani, Barbara Bottazzi, Philippe Denoel, Geert Leroux-Roels, Kent E Kester, Ingileif Jónsdóttir, Robert A van den Berg, Stefan H E Kaufmann, Giuseppe Del Giudice
Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium. Scientific reports 9 (1) (2019)